Stay updated on Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.3, reflecting a new version of the page's build metadata.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe study page now shows recruitment status changes and adds new user guidance sections. It also includes a formatting adjustment to the Intervention/Treatment label.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now shows a new revision tag 'Revision: v3.5.5', replacing the previous 'Revision: v3.5.4', indicating an update to the page's revision history.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. No study content or details on the page were changed.SummaryDifference0.0%

- Check70 days agoChange DetectedThe study location entry has been updated from Taoyuan District, Taiwan, 333 to Taoyuan, Taiwan, 333. This reflects a shift to a city-level designation for the site, which may influence where participants travel to enroll.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a release of the site software rather than changing the clinical trial details.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.